Nitroglycerin Slovakofarma (Glyceryl Trinitrate)

Glyceryl trinitrate, the active ingredient in Nitroglycerin Slovakofarma, is a nitrate vasodilator presented as an oral formulation for oral use. It reduces myocardial oxygen demand and improves coronary blood flow, making it useful in the treatment of angina pectoris, acute coronary syndrome and certain forms of heart failure in adult patients.

GNH USA supplies Nitroglycerin Slovakofarma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and regulatory requirements across all markets.

Nitroglycerin Slovakofarma is used in the management of cardiovascular conditions where reduction of cardiac workload is required.

- Angina pectoris: relieves chest pain by dilating coronary vessels and decreasing myocardial oxygen consumption. - Acute coronary syndrome: improves coronary perfusion and limits ischemic injury during unstable angina or non‑ST elevation myocardial infarction. - Heart failure: reduces preload and afterload, aiding symptom control in patients with chronic heart failure.

Nitroglycerin Slovakofarma may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Headache: throbbing pain often occurring shortly after dosing. - Dizziness or light‑headedness: due to transient hypotension. - Flushing: warm sensation and reddening of the skin. - Nausea or vomiting: gastrointestinal upset. - Tachycardia: compensatory increase in heart rate. - Hypotension: mild to moderate drop in blood pressure.

Serious or Rare Side Effects: - Severe hypotension: marked blood pressure fall leading to syncope. - Syncope: sudden loss of consciousness. - Myocardial infarction: rare worsening of ischemia. - Allergic reaction: rash, itching, or anaphylaxis. - Methemoglobinemia: discoloration of skin and reduced oxygen delivery. - Life‑threatening arrhythmias: such as ventricular tachycardia.

When prescribing Nitroglycerin Slovakofarma, clinicians should observe several safety measures. - Blood pressure monitoring: check for hypotension before and during therapy. - Avoid abrupt discontinuation: taper to prevent rebound angina. - Use caution in anemia: increased risk of tissue hypoxia. - Caution with phosphodiesterase‑5 inhibitors: concurrent use can cause profound hypotension. - Adjust in hepatic impairment: metabolism may be reduced, requiring careful titration. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Nitroglycerin Slovakofarma interacts with several drug classes; awareness of these interactions helps prevent adverse events.

Major Interactions (Avoid): - Other nitrates (e.g., isosorbide dinitrate): additive vasodilation can cause severe hypotension. - Phosphodiesterase‑5 inhibitors (sildenafil, tadalafil): risk of profound blood pressure drop. - Guanylate cyclase stimulators (riociguat): may amplify nitric‑oxide effects leading to dangerous hypotension.

Moderate Interactions (Monitor Closely): - Antihypertensive agents (ACE inhibitors, beta‑blockers): may enhance blood‑pressure‑lowering effect. - Diuretics: can increase risk of volume depletion and hypotension. - Calcium channel blockers: additive vasodilatory effect may require dose adjustment.